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A new role for browning as a redox 
and stress adaptive mechanism?
Yannick Jeanson , Audrey Carrière and Louis Casteilla*
UMR STROMALab, CNRS 5273, INSERM U1031, Université Toulouse III – Paul Sabatier, Toulouse, France
The worldwide epidemic of obesity and metabolic disorders is focusing the attention 
of the scientific community on white adipose tissue (WAT) and its biology. This tissue 
is characterized not only by its capability to change in size and shape but also by its 
heterogeneity and versatility. WAT can be converted into brown fat-like tissue according 
to different physiological and pathophysiological situations. The expression of uncou-
pling protein-1 in brown-like adipocytes changes their function from energy storage 
to energy dissipation. This plasticity, named browning, was recently rediscovered and 
convergent recent accounts, including in humans, have revived the idea of using these 
oxidative cells to fight against metabolic diseases. Furthermore, recent reports suggest 
that, beside the increased energy dissipation and thermogenesis that may have adverse 
effects in situations such as cancer-associated cachexia and massive burns, browning 
could be also considered as an adaptive stress response to high redox pressure and 
to major stress that could help to maintain tissue homeostasis and integrity. The aim of 
this review is to summarize the current knowledge concerning brown adipocytes and 
the browning process and also to explore unexpected putative role(s) for these cells. 
While it is important to find new browning inducers to limit energy stores and metabolic 
diseases, it also appears crucial to develop new browning inhibitors to limit adverse 
energy dissipation in wasting-associated syndromes.
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In the past, brown and white adipocytes were described as classically located in brown and white 
fat, respectively. Although these cells shared the name of adipocytes, their functions were tradition-
ally opposed and those of brown adipocytes were strongly associated with the thermoregulation 
process and energy dissipation. The first discoveries that brown adipocytes could be detected in 
white fat were made in the 1980–1990s and revealed an unexpected plasticity of white adipose tissue 
(WAT), largely driven by β3-agonist, at least in rodents (1–3) and dogs (4). Unfortunately, the lack of 
efficiency of β3-agonist treatment in humans caused interest in this field to wane. However, in recent 
years, the rediscovery of uncoupling protein-1 (UCP1)-expressing cells in white fat together with 
the simultaneous demonstration of the presence of functional brown adipocytes in human adults 
have been accompanied by very new insights into the developmental origins of the different types of 
adipocytes. These ground breaking discoveries have completely changed our view on adipose tissue 
plasticity and generated great enthusiasm associated with a huge number of publications in the 
field, reporting unexpected results. The present review tries to summarize these recent findings and 
discusses new perspectives concerning unexpected roles and functions of UCP1-expressing cells.
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wHiTe ADiPOCYTeS, BROwN 
ADiPOCYTeS, AND ADiPOSe TiSSUe 
PLASTiCiTY: A HiSTORiCAL 
PeRSPeCTive
white Adipocytes
Mature white adipocytes play a fundamental role in energy 
homeostasis and constitute the main stores of energy in the form 
of triglycerides (5). They display variable size (25–200 μm) and a 
unilocular morphology. In addition to their metabolic functions, 
white adipocytes have strong endocrine activity and secrete a 
variety of molecules commonly called adipokines, highlighting 
the fact that adipose tissue has interactions with other organs 
in the body (6). These cells are mainly localized in WAT, which 
are found at distinct anatomical sites. Subcutaneous and visceral 
fat pads (mesenteric, perigonadal, perirenal, etc.) are classically 
distinguished because the subcutaneous WAT has a protective 
action whereas the visceral fat pad is thought to be more deleteri-
ous in the development of obesity and related metabolic diseases 
(type II diabetes, cardiovascular disease, etc.) (7–9).
Brown Adipocytes and UCP1 expression
Brown adipose tissue (BAT) contains brown adipocytes, which 
are smaller (15–60 μm) than white adipocytes and have a multi-
locular morphology (5). Brown adipocytes are highly oxidative 
cells that release energy as heat (10, 11) thanks to their high mito-
chondrial content and to the expression of UCP1. This protein, 
inserted in the inner mitochondrial membrane, acts as a proton 
channel and uncouples the production of ATP by ATP synthase 
from respiratory chain functioning. This leads to the activation of 
catabolism and subsequent heat production. This non-shivering 
thermogenesis plays a key role in body temperature homeostasis 
(10, 11) as definitively demonstrated by UCP1-deficient mice, 
which are cold sensitive (12). Moreover, the presence of large 
amounts of BAT in species like sheep or hibernates, which require 
active thermogenesis to protect the new-born animals from cold 
exposure on a snow-covered pasture in spring or to emerge from 
hibernation, also argues that BAT evolved primarily to function 
as a thermogenic system to maintain body temperature (11, 13). 
BAT is more vascularized than WAT and is probably among the 
most vascularized tissues of the body (14). Such vascularization 
is required for the integrity of BAT. It was recently demonstrated 
that reducing the vasculature specifically in adipose tissues 
induced the whitening of BAT (15). In a temperate environ-
ment, UCP1 is inhibited by di- and triphosphate nucleotides. 
During cold exposure, UCP1 is strongly and quickly activated 
by the sympathetic nervous system (SNS) (16). The local release 
of noradrenaline in BAT activates lipolysis, which induces the 
release of free fatty acids. These constitute not only oxidative 
substrates for brown adipocytes but also potent activators of 
UCP1 (17–19). The same adrenergic stimulus up-regulates the 
expression of UCP1 at the transcriptional level via activation of 
the PKA-p38 mitogen-activated protein kinase signaling pathway 
that induces the phosphorylation and activation of molecular 
transactivators of UCP1 (19, 20). With increasing time of cold 
exposure, SNS triggers a trophic response through activation of 
mitochondriogenesis that also contributes to the increase of the 
global thermogenic capacity of brown adipocytes (21). Recently, 
noradrenaline has also been shown to induce the phosphorylation 
of dynamin-related protein-1, which induces the fragmentation 
of brown adipocyte mitochondria. This fragmentation promotes 
uncoupling and mitochondrial depolarization (22). Lastly, in 
addition to the activation of the thermogenic program of mature 
brown adipocytes, noradrenaline also induces the proliferation 
of brown progenitors through the stimulation of β1-adrenergic 
receptors and their differentiation (23).
In addition to their role in maintaining body temperature, 
brown fat cells possess strong oxidative potential and can thus 
also burn excessive calories (11, 24–26). Transplantation of BAT 
into the visceral cavity of mice fed with a high-fat diet or having 
the ob/ob genetic background increases glucose tolerance and 
improves insulin sensitivity (26, 27). However, UCP1-deficient 
mice are not obese when kept at room temperature (21°C) (12). 
The onset of obesity is only observed when these mice are housed 
at thermal neutrality, exempt from any thermal stress (28). These 
findings underscore the importance of thermogenesis in the 
energy balance of homeothermic animals and can explain the dif-
ferent relative importance of diet-induced thermogenesis related 
to BAT activity according to the developmental status or the spe-
cies (29). Because of their small size, rodents and many new-born 
mammals are permanently in thermogenic deficit, which leads to 
low grade but permanent BAT activation. Despite these limita-
tions, when brown fat cells are stimulated, they exhibit properties 
that offer hope of new therapies as the cells constitute putative 
targets in the fight against metabolic diseases such as diabetes 
and obesity (30).
The beneficial effects of brown adipocytes on energy metabo-
lism are also due to their endocrine/paracrine activity (31). It has 
long been known that brown adipocytes release triiodothyronine 
from thyroxine by their deiodase activity, thus stimulating 
their thermogenic capacity (32). More recently, the secretion of 
fibroblast growth factor-21 (FGF21), besides vascular endothelial 
growth factor, fibroblast growth factor-2, interleukin-6, and neu-
ral growth factor (31, 33–35), has been attracting much attention. 
High levels of FGF21, a protein originally known to be produced 
by the liver in response to fasting, are produced and secreted into 
the bloodstream by BAT, especially during thermogenic activa-
tion (36). FGF21 acts on many tissues, including WAT, the liver, 
pancreas, heart, or central nervous system (31). Furthermore, 
some adipokines, such as leptin, adiponectin, and resistin, 
formerly recognized as specifically secreted by white adipocytes 
(37, 38), are also secreted by brown adipocytes. By analogy with 
the term “adipokines” for proteins secreted by white adipocytes, 
molecules secreted by brown adipocytes have sometimes been 
referred to as “batokines” (26, 31).
Until the discovery of a third type of adipocyte, things were 
very simple and focused on UCP1 only: the absence or presence 
of UCP1 in an adipocyte defined the white or brown pheno-
type, respectively. Thus, many studies investigated the control 
of UCP1 gene expression and first focused on catecholamines 
and thiiodothyronine pathways (19, 39). In addition to cAMP-
dependent responsive element binding protein and thyroid hor-
mone receptor, other molecules, including CCAAT/enhancer 
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binding protein-β transcription factor, retinoic acid receptor, 
activating transcription factor-2, and peroxisome proliferator-
activated receptors gamma and alpha (PPARγ and PPARα), 
strongly up-regulate the expression of UCP1 at transcriptional 
level (40, 41). Among all these regulatory proteins, PPARγ plays 
a pivotal role and mice having non-functional PPARγ exhibit 
brown adipocytes with a unilocular lipid droplet (looking like 
white adipocytes!) and a decrease in UCP1 expression after 
cold exposure (42). The presence of PPARγ agonists, such as the 
anti-diabetic agent rosiglitazone, is required for the expression 
of UCP1 in adipocytes differentiated in primary culture (43). 
Various co-regulators, such as peroxisome proliferator-activated 
receptor coactivator-1α (PGC-1α) and the positive regulatory 
domain containing-16 protein (PRDM16) are also crucial. 
The expression of PGC-1α is regulated by the PKA pathway 
(44) and, in vitro as well as in vivo, overexpression of PGC-1α 
induces the expression of UCP1 along with other mitochondrial 
genes (45–47). In the same manner, specific overexpression of 
PRDM16 in adipose tissue is sufficient to induce browning of 
visceral adipose tissue (48). Furthermore, beside phosphoryla-
tion events that tightly control the activity of transcription fac-
tors and co-regulators, NAD+-dependent deacetylase sirtuin-1 
deacetylates PPARγ on two lysine residues, enabling PRDM16 
recruitment and the subsequent activation of UCP1, in a rosigl-
itazone-dependent manner (49). It should be noted that none of 
these molecular regulators are specific to brown adipocytes and 
UCP1 expression. In particular, PPARγ, which appears crucial 
for the expression of UCP1, also has the great disadvantage of 
promoting white adipocyte differentiation (50).
Adipose Tissue Plasticity: From  
Brown to Brite
As early as 1984, Young et al. described the presence of UCP1-
expressing adipocytes in murine parametrial fat (1). This obser-
vation was more precisely described in later studies by Loncar (2) 
and Cousin et al. (3). Such apparent tissue plasticity was found 
to be strongly promoted after cold exposure or β3-adrenergic 
agonist, including in dogs (4). The relative numbers of these 
cells varies according to the fat pad. Subcutaneous WAT is more 
likely to develop UCP1-expressing cells than other depots such as 
mesenteric and perigonadic WAT. We therefore proposed a gradi-
ent in the plasticity of the different white fat pads similar to that 
described for skeletal muscles, which are classified as glycolytic, 
oxidative, and mixed fiber (3). Two non-exclusive hypotheses 
could explain the emergence of UCP1-expressing adipocytes in 
WAT: de novo differentiation from progenitors and/or transdif-
ferentiation of mature white into brown adipocytes (51). The 
hypothesis of transdifferentiation is supported by several findings 
demonstrating that there is neither an increase in DNA amount 
nor a process of preadipocyte proliferation during acute cold 
exposure in the peri-ovarian adipose tissue (52).
It is noteworthy that, for decades, UCP1-expressing cells in 
white fat were considered as comparable to the classical brown 
adipocytes present in a typical BAT depot, i.e., the interscapular 
BAT. However, recent findings have strongly challenged this view 
and demonstrated that these cells have distinct gene expression 
profiles (53, 54) and different developmental origins (55–58). 
UCP1-expressing adipocytes in white fat thus constitute a third 
type of adipocytes, which have recently been named beige or brite 
(brown in white) adipocytes (43, 54, 59, 60). The development of 
these cells in WAT has been termed the browning process.
A New LOOK ON wAT HeTeROGeNeiTY 
AND PLASTiCiTY: ADiPOCYTeS OF ALL 
COLORS AND ORiGiNS
It was long thought that white and brown adipocytes had a com-
mon progenitor but recent works have challenged this idea. A 
first step came with the proposal that classical brown adipocytes, 
and not brite adipocytes, derived from the paraxial mesoderm, 
particularly the dermomyotome, and that they originated from 
a precursor expressing myogenic transcription factor-5 (Myf5) 
(55). The commitment of the bipotent progenitor to the brown 
phenotype is controlled by members of the TGF-β superfamily, 
such as BMP7 and the PRDM16-C/EBPβ transcriptional com-
plex, which induce the expression of PPARγ and PGC-1α (41, 
61, 62). The common developmental origin of muscle cells and 
typical brown adipocytes is also supported by their very similar 
transcriptional signature (53, 54) and the old observation of 
the presence of glycogen stocks in brown adipocytes (63, 64). 
Furthermore, the demonstration that human skeletal muscle 
contains CD34 positive progenitor cells that can easily differenti-
ate into brown adipocytes is another argument in favor of the 
link between brown adipocytes and skeletal muscle cells (65). The 
common origin of both types of cells could also be related to their 
metabolic activities, which are very close from a bioenergetics 
point of view. Shivering thermogenesis in muscle corresponds 
to the implementation of a futile cycle with a high rate of ATP 
synthesis associated with a high rate of ATP consumption by 
contraction processes. The resulting high oxidative catabolism 
dissipates a large amount of energy as heat. In this case, the func-
tioning of ATP synthase resembles that of a mitochondrial proton 
channel such as UCP1. From a somewhat provocative point of 
view, brown adipocytes could be presented more as specialized 
muscle cells than as specialized adipocytes. Whatever the fate of 
such a hypothesis, this rather simplistic portrayal was quickly 
complicated and the developmental origin of the different types 
of adipocytes does not appear to be as simple as initially proposed. 
While brown adipocytes present in the interscapular BAT are 
thought to derive from Myf5-positive progenitors, those present 
in the brown perirenal and peri-aortic fat pads would originate 
from a Myf5-negative progenitor (56). Furthermore, some white 
and brite adipocytes could also emerge from Myf5-positive cells, 
according to the nature of fat deposits (56, 58). To increase the 
complexity further, it has been proposed that a subpopulation of 
brite adipocytes derives from smooth muscle cell (66).
Like the developmental origin, the cell mechanism(s) at the 
origin of the browning process in adults are not yet clear and 
are still widely debated. Consistently with the transdifferentiation 
hypothesis, a recent study using a transgenic mouse model with 
permanent or temporary staining of UCP1-expressing cells, has 
shown that some “phenotypically white” adipocytes can acquire 
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a brite phenotype (i.e., displaying multilocular droplets together 
with UCP1 expression) after cold exposure (67). Conversely, when 
these mice were returned to 21°C, the brite adipocytes returned 
to a white phenotype (i.e., unilocular droplet), reacquiring a brite 
phenotype after re-exposure to cold (67). In apparent opposition 
to this conclusion, another study has recently demonstrated that 
beige adipocytes arise from de novo differentiation of precursors 
(68). The browning mechanism would also rely on different 
cell mechanisms according to the nature of the fat pad. While 
UCP1-expressing adipocytes within subcutaneous WAT would 
arise from the transdifferentiation phenomenon, those from the 
epididymal fat pad would originate from the proliferation and 
the differentiation of progenitor cells (69, 70). Adding to this 
complexity, it should not be forgotten that non-stimulated brite 
adipocytes could have a phenotype very close to that of the white 
adipocyte. This phenotype homology could lead to a misinter-
pretation of browning as a white adipocyte transdifferentiation 
when it could simply correspond to the activation of inactive 
brite adipocytes. It is noteworthy that, whatever the intensity 
of the stimuli, some unilocular white cells are totally refractory 
to cell plasticity. This would also mean that different types of 
unilocular cells lacking UCP1 expression could co-exist inside 
the same fat pad.
The compilation of these findings shows the current confu-
sion, which is probably due to the underestimated complexity 
of the system. It seems that there are several pathways and 
developmental origins that give rise to unilocular UCP1 nega-
tive adipocyte(s) and to multilocular UCP1 positive adipocyte(s), 
without anyone knowing if cells having a similar apparent phe-
notype have the same functions and carry out the same regula-
tions. This also emphasizes the lack of relevant, robust tools to 
identify and distinguish the different types of adipocytes because 
the white adipocyte phenotype is defined by its lack of brite or 
brown adipocyte markers, which is clearly insufficient. Although 
a large number of markers specifically expressed in each type of 
adipocytes or precursors have been proposed from gene expres-
sion profiling of isolated white, brown, and brite adipocytes 
and/or from studies on whole adipose tissues, their validity is 
currently under investigation (71). This kind of approach does 
not really take account of the heterogeneity of cells inside the 
tissues. Even in conditions of browning such as cold exposure, 
brite adipocytes represent only a small proportion of the tissue 
cells and this can lead to a biased view grouping white and brite 
adipocytes together. It is therefore necessary to characterize the 
different adipocytes in homogeneous cell populations. Also, we 
cannot exclude the possibility that typical brown adipocytes 
could co-exist with brite adipocytes in the same white fat pad 
since brite adipocytes can co-exist with typical brown adipocytes 
in typical brown fat pad.
UNeXPeCTeD BROwNiNG iNDUCeRS 
ReveAL PUTATive New ROLeS FOR 
UCP1-eXPReSSiNG ADiPOCYTeS
After the old failure of β3-agonist treatment in humans, the 
discovery of functional brown fat in adult humans has revived 
the research. Besides the adrenergic pathway that represents the 
ancestral and best described activator of UCP1 expression and 
in addition to thyroid hormones, several peptides have recently 
been identified as browning inducers or inhibitors that cor-
respond to as many therapeutic targets. Several recent reviews 
summarize the different regulators of the browning process (41, 
72–74). We decided to focus on the unexpected physiological or 
physio-pathological conditions recently found to regulate the 
browning process and that highlight putative new functions for 
these cells (Figure 1).
Browning as an Adaptive element in 
Redox Metabolism?
While an increasing number of agents have been reported to 
stimulate browning as discussed, very few studies have inves-
tigated the role of the metabolic environment in the phenom-
enon. We recently demonstrated the unexpected role of redox 
metabolites, such as lactate, in the browning process. Lactate, 
which is a major product of anaerobic metabolism, promotes 
WAT browning through its transport by the monocarboxylate 
transporters (75). Lactate-induced browning is mediated 
by a change in the intracellular redox state (Figure  2). The 
transformation of lactate into pyruvate by lactate dehydroge-
nase B induces a higher NADH/NAD+ ratio and modulation 
of this ratio by different strategies modulates the expression 
of UCP1 (75). As, in turn, uncoupling the ATP production 
from the respiratory chain by high levels of UCP1 accelerates 
the oxidation of NADH by the complex I, we postulate that 
browning constitutes an adaptive mechanism to alleviate a 
strong redox pressure (75) (Figure 2). The increased expres-
sion of the lactate-importing transporter during activation 
of UCP1-expressing adipocytes, e.g., after cold exposure (75) 
suggests that lactate could also be used as a substrate by these 
cells. We postulate that, in the same way as for glucose and 
triglyceride homeostasis, UCP1-expressing cells could regulate 
plasma lactate levels and lactate metabolism. We propose 
that there is a redox regulatory loop where lactate induces a 
metabolic reprograming of adipocytes toward an uncoupled 
oxidative phenotype that, in turn, favors lactate consumption 
and dissipation.
This points to a totally new function for brite adipocytes and 
extends the role of lactate as a signaling molecule in the brown-
ing field. This signaling pathway could also be involved in the 
emergence of UCP1-expressing adipocytes in white fat during 
obesity. WAT is an important producer of lactate in physiologi-
cal conditions (76, 77). It could be postulated that, in an obesity 
context where large adipocytes are hypoxic, they could locally 
produce large amounts of lactate that would stimulate the brown-
ing of neighboring white adipocytes and/or the recruitment of 
brite progenitors that promote energy dissipation (77). This link 
between browning and redox state is also emphasized by two 
recent studies, demonstrating that UCP1 expression is strongly 
controlled by different redox elements such as oxidative stress and 
antioxidant defenses. Sestrins, stress-inducible proteins that limit 
oxidative stress, inhibit UCP1 expression (78) while glutathione 
deficit, one of the key elements of the cytosolic antioxidant 
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defenses, increases it (79). Oxidative stress and redox state thus 
constitute new and important regulators of UCP1 expression.
Browning as a Non-Specific Stress 
Response?
Three unexpected physiological or pathophysiological situations 
were found to be associated with browning: exercise, cancer-
associated cachexia, and burns. Before our findings, physical 
exercise had been shown to activate BAT and WAT browning 
(80, 81). In addition to IL-6 (82), two muscle-derived hormones, 
irisin and meteorin-like, are believed to mediate such effects 
(80, 83). The expression and the impact of irisin in humans have 
been strongly debated but its existence has been unequivocally 
demonstrated by a recent study using tandem mass spectrometry 
(84). Irisin is detectable in the blood of untrained persons during 
exercise or exposure to low temperatures (84, 85). While some 
studies have shown that irisin has no effect on the differentiation 
of human preadipocytes toward the brite phenotype (86), others 
have demonstrated that irisin activates the thermogenic activity 
of preadipocytes extracted from human neck (87). Additional 
signals, including lactate, whose plasma levels rise strongly dur-
ing physical activity, could also contribute to exercise-induced 
UCP1 expression (75). The second situation, cachexia, is related 
to physiopathology associated with wasting syndromes, such as 
FiGURe 1 | Classic and new regulators of browning. The induction of browning is classically described after cold exposure or high-fat diet and leads to the 
generation of heat and energy dissipation. In this context, browning represents a relevant target to fight against metabolic diseases. More recently, unexpected 
physiological or physio-pathological situations were also described as new browning inducers. These findings shed the light on putative and unexpected roles of 
browning such as redox and oxidative stress dissipation and inflammation modulation. On the other hand, the automatic association with heat and energy 
dissipation could appear as adverse side effects that will be necessary to control. The design of browning antagonists will be then relevant.
diabetes, sepsis, and cancer (88). It results in chronic inflammation 
and severe weight loss associated with atrophy of fat deposits and 
muscles. It is often associated with high plasma levels of lactate 
and usually precedes the death of the patient (89). Several stud-
ies have demonstrated that cachexia induced by the injection of 
cancer cells is associated with browning of WAT and an increase 
in energy expenditure (90–92). Inflammation and, especially, the 
production of interleukin-6 play a key role in this phenomenon 
and the lack of interleukin-6 receptor blocks browning induced 
by cancer cells (90). Parathyroid hormone-related protein may 
also mediate cancer-cell-induced browning of WAT (91). Lastly, 
in addition to exercise and cachexia, severe burns are associated 
with hypermetabolic response, hyperthermia, and browning in 
rodents and in humans (93, 94).
The role(s) of UCP1-expressing cells in these different 
conditions still remain to be unraveled. The fact that muscle 
contraction during exercise promotes the emergence and activa-
tion of energy-dissipating and thermogenic cells does not seem 
physiologically consistent with the energy conservation theory. 
This discrepancy would be explained if muscle-derived signals 
that induce browning could be shown to have evolved from 
shivering-related muscle contraction (87). In this scenario, WAT 
browning would represent a coherent and additive mechanism in 
thermoregulation promoted by shivering. For cachexia, associ-
ated browning could constitute an adaptive thermoregulatory 
FiGURe 2 | Browning as a redox responsive mechanism. The import of lactate via the monocarboxylate transporter MCT1 is associated with a redox state 
(NADH/NAD) increase which, in turn, triggers the expression of browning genes including UCP1. The effect of activated UCP1, which is inserted into the inner 
mitochondrial membrane, is to uncouple the respiratory chain function from the ATP synthesis. The subsequent increase in oxidative metabolism generates heat and 
oxidizes reduced equivalents such as NADH, which was at the origin of the up-regulated UCP1 expression.
October 2015 | Volume 6 | Article 1586
Jeanson et al. New emerging roles for browning
Frontiers in Endocrinology | www.frontiersin.org
response to fight against the hypothermia associated with the 
decrease of both fat insulation and heat-related muscle mass 
observed during cachexia. Addressing this issue would require 
these results to be reproduced at thermoneutrality, as illustrated 
by the study conducted by Champigny et al. in starving conditions 
(95). In this study, the authors found an up-regulation of UCP1 
expression and brown adipocyte activation during starvation, 
which are physiologically inconsistent (95). In fact, starvation-
induced UCP1 expression disappeared when mice were kept at 
thermoneutrality, suggesting that UCP1 up-regulation was an 
adaptive thermogenic response of rats to fight against the tem-
perature deficit associated with starvation-induced torpor (95). 
Browning is always associated with thermoregulation responses 
in these situations but could have adverse metabolic effects that 
need to be controlled. For massive burn injury, browning would 
be triggered by the large stress release of catecholamine and 
inflammatory signals and would participate in the increase of the 
whole body metabolic rate (94). In fact, the role of inflammatory 
signals and cytokines on the browning process was first reported 
during cold exposure (96). Cyclooxygenase-2, whose expression 
is increased in WAT during cold exposure, is thought to trigger 
the browning process through the synthesis of prostaglandins 
E2 and I2 (97, 98). The link between prostaglandins and UCP1 
is not new and it has been proposed that the natural ligand of 
PPARγ is prostaglandin PGJ2 (99). However, these results have 
been questioned following the recent publication of the opposite 
effect of prostaglandins E2 and F2α on the expression of UCP1 
(100). Surprisingly, immune cells are involved in cold-induced 
browning as eosinophils express and secrete interleukin-4 and 
interleukin-13, which recruit alternative M2 macrophages in 
the subcutaneous WAT during cold exposure (101). These 
macrophages secrete catecholamines that induce browning. 
The meteorin-like hormone secreted by both WAT and BAT 
during cold exposure or during physical exercise has the same 
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effect on eosinophils (83). At the same time, another group has 
demonstrated that the activation by interleukin-33 of Group  2 
innate lymphoid cells (ILC2s), known for their role in tissue 
remodeling, could also induce the recruitment of eosinophils via 
the release of interleukin-13 (102). ILC2s may also, in response 
to interleukin-33, produce and secrete methionine-enkephalin, 
a new browning inducer (103). Although all these mechanisms 
were discovered in the context of cold exposure, it is reasonable to 
speculate that any events able to activate ILC2s or eosinophils are 
able to promote browning. Together with the fact that interferon 
regulatory factor-4 controls UCP1 expression (104), these obser-
vations bring to light an undiscovered link between browning 
and inflammation/immunity.
The consequences of the apparition of UCP1-expressing cells 
in such inflammation- and injury-related scenarios currently 
remain poorly understood but it is noteworthy that the common 
point between all the situations is the notion of intense stress 
and inflammation. For this reason, with the limits concerning 
thermoregulation discussed previously and although these 
fields are evolving rapidly, we can already assume that browning 
could appear in any severe stress conditions. Whether these cells 
have positive or negative effects on such stress and loss of tissue 
homeostasis conditions is unknown (Figure 1). They could have 
adverse effects through increased energy dissipation in wasting 
syndromes and injury conditions but also could play positive roles 
through unexpected functions such as redox and oxidative stress 
dissipation, metabolite consumption, or even anti-inflammatory 
actions. This is an underexplored scientific area that will remain 
very open for the coming years.
PeRSPeCTiveS iN HUMANS
In humans, it has long been considered that BAT is only present 
in neonates, with some exceptions such as patients suffering 
from pheochromocytoma (105, 106) or workers exposed to 
cold temperatures (107). Mainly localized in the interscapular 
region like the main murine BAT depot, the BAT present 
in new-born babies enables heat to be produced to combat 
the thermal stress associated with birth. While this fat pad 
disappears rapidly and is absent in human adults like in adult 
sheep (13), some histological studies performed in the 1970s 
claimed that human adults possessed some brown fat deposits 
in additional zones, including around the kidney, heart, and 
adrenal gland, and along the aorta and carotid (108). However, 
these studies were unable to change the general opinion that 
human adults did not possess BAT. Recently, this view has been 
contradicted by medical imaging based on the measurement of 
glucose uptake (using 18-fluorodesoxyglucose associated with 
positron emission tomography–computed tomography) This 
approach, widely used in oncology to detect tumors, when 
associated with histological and immunocytochemistry stud-
ies, highlighted the presence of BAT in healthy human adults 
(109–112). The activity of BAT is inversely correlated with body 
mass index, suggesting that it could play a role in energy homeo-
stasis (109–112). Given their high oxidative potential and their 
ability to consume nutrients such as glucose and triglycerides, 
brown adipocytes in humans possess very attractive proper-
ties for fighting against metabolic diseases, including type II 
diabetes and obesity (30). While molecular profiling studies 
have shown that human brown adipocytes are very similar to 
brite adipocytes described in mice (59, 113, 114), some others 
claim that brown fat deposits in humans are made of a mixture 
of brown and brite adipocytes, the differential distributions of 
which appear to depend on their anatomical location, consist-
ently with our previous remarks. In the neck region, brown 
adipocytes would be located deep within the tissues and 
brite adipocytes rather at the surface (115, 116). The search 
for brite progenitors in human WAT led to the discovery of 
bipotent (white and brite) progenitors that expressed the tissue 
non-specific alkaline phosphatase marker (117), while CD29 
enabled the isolation of brown progenitors present in the deep 
regions of the human neck (118). Among the putative targets 
(72), we cannot ignore the β3-adrenergic pathway. Although 
many efforts failed to find suitable compounds (119), new 
pharmacological and genetic studies have revealed that target-
ing this pathway could be efficient (120–122). While PPARγ is 
a very potent inducer of UCP1 expression, it also causes many 
side effects, including body weight gain and cardiovascular 
issues, that strongly impair its therapeutic use (50). One way to 
bypass this issue would be to design a selective PPAR modula-
tor (123, 124). Recently, oral supplementation of the bile acid 
chenodeoxycholic acid has been shown to activate BAT and to 
increase whole body energy expenditure in humans, making 
bile acids attractive candidates for counteracting obesity and 
related metabolic diseases (125).
By contrast, recent works on inflammation and burns have 
also revealed the bad and the ugly of browning as previously 
described. While it is important to find new browning inducers to 
limit energy stores and metabolic diseases, it also appears crucial 
to develop new browning inhibitors to limit adverse energy dis-
sipation in wasting-associated syndromes.
CONCLUSiON
All these recent discoveries constitute a very active field 
attracting groups of scientists who are expert not only in 
metabolism but also in immunology, development, cancer, 
etc. This has shed new and unexpected light on brown and 
brite adipocytes and has already given original insights into 
the putative role of these cells. For the future, it is reasonable 
to speculate that the story is not finished because this field 
is now wide open and raises new questions and hypotheses, 
keeping in mind the key ancestral role of UCP1 in thermo-
genesis and bioenergetics.
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